Soleno Therapeutics (SLNO) Treasury Shares (2013 - 2026)

Soleno Therapeutics (SLNO) has 12 years of Treasury Shares data on file, last reported at $1.2 million in Q1 2026.

• On a quarterly basis, Treasury Shares rose 220.05% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 220.05% increase from a year earlier, with the FY2025 full-year figure at $443291.0, down 52.83% from the prior year.
• Treasury Shares for Q1 2026 stood at $1.2 million, up from $443291.0 in the prior quarter.
• Over the last five years, Treasury Shares for SLNO reached as high as $1.2 million in Q1 2026 and fell as low as $9534.0 in Q1 2023.
• Historically, Treasury Shares has averaged $409174.1 across 5 years, with a median of $361991.0 in 2025.
• Across the five-year window, Treasury Shares sank 96.7% in 2023 and jumped 5950.37% in 2024, its largest moves.
• Year by year, Treasury Shares stood at $19068.0 in 2022, then slipped by 18.53% to $15534.0 in 2023, then soared by 5950.37% to $939865.0 in 2024, then plunged by 52.83% to $443291.0 in 2025, then soared by 161.35% to $1.2 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $1.2 million in Q1 2026, $443291.0 in Q4 2025, and $469769.0 in Q3 2025.